The present investigation of albumin metabolism in Cushing's syndrome employing the I'3'-labeled albumin turnover method (1) was undertaken in view of clinical and experimental evidence of significant effects of steroid hormones upon protein metabolism. Previous reports have described acute effects of large doses of glucocorticoids in human subjects (2-4). The effects of chronic hyperadrenalism were examined in the present work.
The present investigation of albumin metabolism in Cushing's syndrome employing the I'3'-labeled albumin turnover method (1) was undertaken in view of clinical and experimental evidence of significant effects of steroid hormones upon protein metabolism. Previous reports have described acute effects of large doses of glucocorticoids in human subjects (2) (3) (4) . The effects of chronic hyperadrenalism were examined in the present work.
MATERIAL AND M ETHODS

Clinical inaterial
The following four categories of subjects were studied: 1) normal volunteers, 2) physically healthy hospitalized schizophrenic patients, 3) cases of Cushing's syndrome due to adrenal cortical hyperplasia; and 4) a patient with Cushing's syndrome due to exogenous steroids. 1) Normiial volunteers. Thirteen subjects, 10 male, 3 female with ages ranging from 19 to 40 years.
2) Physically healthy hospitalied schizophrcnic patients. Ten subjects, 5 male, 5 female with ages ranging from 17 to 39 years.
3) Cushing's syndromiie. Albumin turnover studies were carried out on 4 women during the active stage of clinically typical Cushing's syndrome attributed to bilateral adrenal hyperplasia. Three of the 4 were studied again after therapy and remission. The diagnoses were supported by elevated urinary ketogenic steroids or corticoids (Porter-Silber chromogens). In MWI.W., administration of prednisone was followed by suppression of urinary 17-ketosteroid levels. In the other 3 subjects, intravenous ACTH was followed by an exaggerated rise in plasma corticoids, considered indicative of hyperplasia rather than tumor (5) . None of the women exhibited appreciable virilization. All had amenorrhea; the 3 of pre-menopausal age resumed menstruation after therapy.
M.W., aged 36, had severe Cushing's syndrome with osteoporosis and collapsed lumbar vertebrae, hypertension, intermittent hypokalemic alkalosis, and increased * Supported by grants from the National Institutes of Health, the American Cancer Society, and the National Foundation for Neuromuscular Diseases, and by a research contract with the U. S. Atomic Energy Commission. requirement of insulin for diabetes mellitus which apparently antedated the onset of hyperadrenalism. After complete removal of enlarged adrenal glands, the patient resumed menstruation for the first time in several years. She was given relatively large steroid doses in an effort to minimize orthostatic hypotension and episodes of Addisonian crisis associated with intercurrent infections. When restudied with IP3`-albumin 15 months after total adrenalectomy, the patient was receiving 30 mg cortisol, 0.5 mg 9-a-fluorocortisol, and 1 g tolbutamide daily.
C.H., aged 50, had Cushing's syndrome of moderate severity with hypertension but nio diabetes or osteoporosis. She had facial rounding, cervico-dorsal and supraclavicular fat pads, and thin skin with a few pink striae. She had been emotionally disturbed and required care in a mental hospital during bo1th initial and follow-up studies. She was restudied with P`31-albumin 10 months after total adrenalectomy, while receiving 20 mg cortisone daily.
R.H., aged 32, had Cushing's syndrome of minimal severity with hypertension but no impaired glucose tolerance or osteoporosis. She had some facial rounding, hirsutism, amenorrhea, easy bruisability, and increased pigmentation. Following irradiation of the pituitary (4,080 r), the elevated urinary 17-ketosteroids and ketogenic steroids fell to the normal range. Menses reappeared for the first time in 7 months. The patient's general appearance was improved at the time of the second I3_-albumin study 10 months after radiotherapy.
A The radioiodinated serum albumin shipments were obtained from E. R. Squibb and Sons or from Abbott Laboratories. Immediately upon receipt of each lot from Abbott Laboratories, carrier albumin (25 to 50 mg Red Cross albumin) was added to the vial to minimize radiation damage to the labeled protein (6) . The Squibb solutions were stated to contain about 10 to 15 mg protein per ml, which was considered satisfactory from the standpoint of self-irradiation.
Each hyperadrenal patient was studied simultaneously with two or more control subjects to avoid any possible discrepancies that could arise from different behavior it vivo of individual shipments of radioiodinated albumin. No variation between different lots was observed. Urine collections during the first day after injection revealed that amounts not exceeding 10 per cent of the injected radioactivity had been excreted, a finding compatible with absence of appreciable amounts of abnormal rapidly degraded components (1, 7).
After 1 day or more of iodine prefeeding (Lugol's solution, 15 drops daily), the subjects received 50 to 100 ,uc of J?'1-labeled albumin by intravenous injection. Heparinized venous plasma samples were obtained 10 minutes after injection, and daily or three times weekly for three or more weeks.
In several of the experimental and control subj ects, 24-hour urine collections were obtained during most or all of the study period. The completeness of the collections was verified by creatinine determinations.
The plasma samples of each subject were counted with appropriate standards in a well-type scintillation counter, usually at the conclusion of the study, thus obviating the need for physical decay corrections. Other samples, including urines, were corrected when necessary for physical decay.
The data on plasma radioactivity were treated as originally described (1) . Disappearance curves were obtained from semilogarithmic plots of the plasma radioactivity against time (Figures 2 and 3 ). The rapid initial fall of the first few days, attributed to distribution of the tracer throughout the "total exchangeable albumin pool," was followed by a gradual linear decline, the exponential decay due to metabolic degradation. Lines were drawn by inspection, or by the method of least squares when the points showed appreciable scatter. The half-time (TJ) of the slow component was obtained by graphic analysis. From the Ti the equation, 0.693/Ti = k, gave the fractional turnover rate, k, expressed as per cent of the albumin pool replaced per day. The total exchangeable albumin pool in grams was obtained by the isotope dilution formula, employing the quotient: total radioactivity injected radioactivity per gram of albumin
The denominator was obtained from the zero time extrapolation of the slow component which represented plasma radioactivity if distribution had occurred instantaneously upon injection. The product of the pool and turnover rate yielded the degradation rate in grams per day. The rate of synthesis should be the same as the degradation rate under steady state conditions, which were assumed to exist in the absence of significant clinical alterations. The observed constancy of the serum albumin concentration was compatible with this assumption. The data for the albumin pools and degradation rates were adjusted to 1.73 m2 surface area. The intravascular albumin (circulating plasma albumin) in grams was calculated from the 10 minute value for radioactivity per gram of albumin used as the denominator in the isotope dilution formula.
The data on urinary radioactivity were treated by two types of computation described by Rothschild, Schreiber, Oratz and McGee (2) and by Berson, Bauman and Rothschild (7) (8) (9) . One value for the albumin degradation rate was obtained from the quotient:
per cent renal excretion per day per cent injected radioactivity retained in the body' which was multiplied by the total exchangeable albumin pool (7, 8) . A second value was the product of the "metabolic clearance" of P`31-albumin and the mean serum albumin concentration (2, 9). The results of both methods based upon urinary data proved to be in reasonable agreement with the values obtained from plasma disappearance curves, which were used in Table I and in Figures 1, 2 and 3 . Extensive discussions of the validity and limitations of P1`3-albumin turnover studies have appeared previously (6, 7, (10) (11) (12) (13) . RESULTS 
AND INTERPRETATIONS
The normal control and schizophrenic groups had biological half-times of albumin turnover (mean + standard deviation) of 13.4 + 1.3, and 13.5 + 1.3 days, respectively ( Figure 1 and Table I ). No significant variation related to age or sex was observed. Human subj ects started on large doses of glucocorticoids have manifested acutely increased albumin degradation, according to the reports of Rothschild and co-workers (2), Grossman, Yalow and Weston (3), and Blythe and associates (4) . Accelerated albumin turnover is by no means confined to Cushing's syndrome. It is seen in thyrotoxicosis (11, 14) as well as in the hypoproteinemias associated with proteinuria (8, 13, 14) and with gastrointestinal protein-wasting syndromes (15) (16) (17) (18) . It is not, however, regularly associated with either malnutrition (14, 19) or debilitating illness. Subjects with marked wasting, including patients with advanced carcinoma, myotonic muscular dystrophy, and miscellaneous muscle diseases did not have accelerated albumin turnover, although some subjects had marked hypoalbuminemia and diminution of the total exchangeable albumin pool (14) . This finding would tend to exclude the possibility that the accelerated turnover in Cushing's syndrome might be attributable to nonspecific effects of severe illness. The close similarity of the findings in the normal control and schizophrenic groups signifies the constancy of albumin metabolism despite emotional illness and wide variations in behavior.
The mechanism of the accelerated albumin turnover in Cushing's syndrome cannot be stated ex- plicitly at present. Certain inferences are warranted, however. In the absence of significant clinical alterations and with constancy of the serum albumin concentration, the subjects were considered to be in a "steady state" during the several weeks of each study. Therefore, the rate of synthesis was presumed to be equal to the rate of degradation. After therapy and remission, the computed degradation rate fell in two of the three cases; the albumin pool rose in each. Since the total exchangeable albumin values were not markedly diminished in active Cushing's syndrome (Table I) , it may be inferred that accelerated albumin catabolism was at least partly compensated for by increased synthesis of albumin. The diminution in albumin pool associated with hormone treatment was definitely less than that expected from the increased degradation rate. Thus, in four miiale sul)jects, the authors reported a mean figure of 59 g as the increase in albumin degraded during steroid administration. Since the nmean diminution in albutmin pool was only 31 g, the difference, 28 g, was attributed to increased albumin synthesis. Even allowing for errors implicit in the methodology, it would appear likely from these data and from the present report, that glucocorticoids increase albumin synthesis as well as degradation under both short-term and longterm conditions.
The promotion of increased gluconeogenesis by adrenal cortical hormones has been the subject of much work since the animal experiments of Long, Katzin, and Fry (20) and the clinical observations of Albright (21) . The detailed study by Hoberman (22) (24) . Clark carried out analyses of the carcasses and livers of control and cortisone-treated rats which were given N"5-glycine (25 In the present group of patients who showed no appreciable virilization, the abnormalities were ascribed to the demonstrated excess of 17-hydroxycorticosteroids, which were not subjected to further analysis, such as chromatographic separation. The findings in virilizing adrenal disorders and the effects of the adrenal androgen, de- hydroisoandrosterone (28) , remain to be explored. 1 . 1131-labeled albumin turnover studies were carried out in four patients with Cushing's syndrome due to adrenal cortical hyperplasia and in control subjects.
2. In active Cushing's syndrome there was a short biological half-time of the tracer, signifying accelerated turnover.
3. This abnormality was reversed after therapy and remission.
4. Cushing's syndrome due to the administration of cortisone also revealed accelerated albumin turnover, more pronounced with a larger dose.
5. The total exchangeable albumin pool was reduced in Cushing's syndrome, and was smallest in the two subjects with the shortest half-times and with the most severe clinical manifestations.
6. Excess glucocorticoids were considered to have produced accelerated albumin catabolism, partly comiipensated for by increased synthesis.
